Cardiac Catheterization Research - Division of Cardiovascular Medicine ::

Cardiac Catheterization Research

Faculty

Michael H. Sketch Jr., MD
J. Kevin Harrison, MD
Brian H. Annex, MD
Thomas M. Bashore, MD
Peter B. Berger, MD
Lawrence E. Crawford, MD
Thomas R. Gehrig, MD
Robert A. Harrington, MD
David E. Kandzari, MD
David F. Kong, MD
Mitchell W. Krucoff, MD
Kenneth G. Morris, MD
John L. Petersen II, MD
Harry R. Phillips III, MD
Thomas J. Povsic, MD , PhD
Sunil V. Rao, MD
James E. Tcheng, MD

Andrew Wang, MD
James P. Zidar, MD

The Cardiac Catheterization Research Laboratory is responsible for the development and testing of new cardiac catheterization therapies, with a focus on novel techniques and devices, for the treatment of acute and chronic coronary and peripheral arterial disease and valvular heart disease.

Site-based research efforts include initiation and oversight of clinical trials or registries which offer novel treatments or insights for these conditions. Cardiovascular Medicine fellows obtaining sub-specialty training in interventional cardiology are actively involved in subject screening, recruitment, protocol implementation, and are encouraged to pursue their own research project with mentorship by the faculty of the Duke Cardiac Catheterization Laboratory.

Selected Publications

Cardiac Catheterization Lab Faculty were primary author or co-author in 109 publications in calendar year 2004. Some of these important contributions include:

Bittl JA, Chew DP, Topol EJ, Kong DF, Califf RM: Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, atherotomy or laser angioplasty. Journal of the American College of Cardiology 43:936-942, 2004.
Dery JP, Braden GA, Lincoff AM, Kereiakes DJ, Browne K, Little T, George BS, Sane DC, Cines DB, Effron MB, Mascelli MA, Langrall MA, Damaraju L, Barnathan ES, Tcheng JE. Final results of the ReoPro readministration registry. Am J Cardiol 93:979-84, 2004.
Kandzari DE, Berger PB, Kastrati A, Steinhubl SR, Mehilli J, Dotzer F, ten Berg JM, Neumann Franz-Josef, Bollwein H, Dirschinger J, Schömig A. Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization. J Am Coll Cardiol. 44:2133-2136, 2004.
Petersen JL, Mahaffey KW, Hasselblad V, Antman EM, Cohen M, Goodman SG, Langer A, Blazing MA, Le-Moigne-Amrani A, deLemos JA, Nessel CC, Harrington RA, Ferguson JJ, Braunwald E, Califf RM. Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview. JAMA. 292:89-96, 2004.
Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PA, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. The relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 292:1555-1562, 2004.